CERC: Multiple Catalysts Upcoming in 4Q16

By David Bautz, PhD NASDAQ:CERCBusiness UpdateCerecor, Inc. (NASDAQ:CERC) is a clinical stage biopharmaceutical company developing treatments for patients with neurological and psychiatric disorders....